IHAM
ORIC icon

Integral Health Asset Management’s Oric Pharmaceuticals ORIC Stock Holding History

Integral Health Asset Management’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.7M Buy
1,400,000
+200,000
+17% +$2.27M 0.85% 30
2025
Q4 		$9.82M Buy
1,200,000
+300,000
+33% +$3.45M 0.49% 59
2025
Q3 		$10.8M Sell
900,000
-350,000
-28% -$3.68M 0.73% 49
2025
Q2 		$12.7M Buy
+1,250,000
New +$8.39M 1.16% 30

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Integral Health Asset Management's ORIC Position: Q1 2026 in Review

Integral Health Asset Management increased its Oric Pharmaceuticals (ORIC) stake by 17% in Q1 2026, buying an estimated $2.27M and bringing the position to 1,400,000 shares worth $17.7M. The position accounts for 0.85% of the portfolio, ranked #30.

Integral Health Asset Management first reported a position in ORIC in Q2 2025 and has held it in 4 quarters since. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • Integral Health Asset Management held 1,400,000 shares of Oric Pharmaceuticals worth $17.7M as of Q1 2026.
  • Integral Health Asset Management bought 200,000 Oric Pharmaceuticals shares in Q1 2026, an estimated $2.27M.
  • Oric Pharmaceuticals made up 0.85% of Integral Health Asset Management's portfolio in Q1 2026, its #30 holding.
  • Integral Health Asset Management first reported a position in Oric Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Integral Health Asset Management's 13F filing for Q1 2026, filed 15 May 2026.